Clinical trial

Does Medicinal Mushroom Agaricus Blazei Protect Against Allergy and Asthma?

NCT03198455

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-01

PhaseNA

Study timeline

Study start (actual)2016-02-01Date precision: month

Registry last updated2017-06-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pollen; Allergy, Asthmaunresolved

Interventions

Agaricus blazei Murill-based mushroom extract, Andosan™DIETARY_SUPPLEMENT

PlaceboOTHER

Sponsors & collaborators

Oslo University Hospitallead sponsor

University of Oslocollaborator

ImmunoPharma AScollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03198455 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.